These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17098188)

  • 1. Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2.
    McDevitt CA; Collins RF; Conway M; Modok S; Storm J; Kerr ID; Ford RC; Callaghan R
    Structure; 2006 Nov; 14(11):1623-32. PubMed ID: 17098188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multidrug resistance half-transporter ABCG2 is purified as a tetramer upon selective extraction from membranes.
    Dezi M; Fribourg PF; Di Cicco A; Arnaud O; Marco S; Falson P; Di Pietro A; Lévy D
    Biochim Biophys Acta; 2010 Nov; 1798(11):2094-101. PubMed ID: 20691149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2.
    Xu J; Liu Y; Yang Y; Bates S; Zhang JT
    J Biol Chem; 2004 May; 279(19):19781-9. PubMed ID: 15001581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant synthesis of human ABCG2 expressed in the yeast Saccharomyces cerevisiae: an experimental methodological study.
    Jacobs A; Emmert D; Wieschrath S; Hrycyna CA; Wiese M
    Protein J; 2011 Mar; 30(3):201-11. PubMed ID: 21424391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the lipid environment, cholesterol and bile acids on the function of the purified and reconstituted human ABCG2 protein.
    Telbisz Á; Özvegy-Laczka C; Hegedűs T; Váradi A; Sarkadi B
    Biochem J; 2013 Mar; 450(2):387-95. PubMed ID: 23205634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and structural analyses of ABCG2.
    McDevitt CA; Collins R; Kerr ID; Callaghan R
    Adv Drug Deliv Rev; 2009 Jan; 61(1):57-65. PubMed ID: 19124053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detergent-free purification of ABC (ATP-binding-cassette) transporters.
    Gulati S; Jamshad M; Knowles TJ; Morrison KA; Downing R; Cant N; Collins R; Koenderink JB; Ford RC; Overduin M; Kerr ID; Dafforn TR; Rothnie AJ
    Biochem J; 2014 Jul; 461(2):269-78. PubMed ID: 24758594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.
    Ozvegy C; Váradi A; Sarkadi B
    J Biol Chem; 2002 Dec; 277(50):47980-90. PubMed ID: 12374800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional structure of the human breast cancer resistance protein (BCRP/ABCG2) in an inward-facing conformation.
    Rosenberg MF; Bikadi Z; Hazai E; Starborg T; Kelley L; Chayen NE; Ford RC; Mao Q
    Acta Crystallogr D Biol Crystallogr; 2015 Aug; 71(Pt 8):1725-35. PubMed ID: 26249353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity.
    Xu J; Peng H; Chen Q; Liu Y; Dong Z; Zhang JT
    Cancer Res; 2007 May; 67(9):4373-81. PubMed ID: 17483351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter.
    Clark R; Kerr ID; Callaghan R
    Br J Pharmacol; 2006 Nov; 149(5):506-15. PubMed ID: 16981002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface.
    Ozvegy-Laczka C; Várady G; Köblös G; Ujhelly O; Cervenak J; Schuetz JD; Sorrentino BP; Koomen GJ; Váradi A; Német K; Sarkadi B
    J Biol Chem; 2005 Feb; 280(6):4219-27. PubMed ID: 15557326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional structure by cryo-electron microscopy of YvcC, an homodimeric ATP-binding cassette transporter from Bacillus subtilis.
    Chami M; Steinfels E; Orelle C; Jault JM; Di Pietro A; Rigaud JL; Marco S
    J Mol Biol; 2002 Feb; 315(5):1075-85. PubMed ID: 11827477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D structure of the transporter ABCG2-What's new?
    Eckenstaler R; Benndorf RA
    Br J Pharmacol; 2020 Apr; 177(7):1485-1496. PubMed ID: 31985041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2.
    Han B; Zhang JT
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):31-42. PubMed ID: 14754410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the function of the human ABCG2 multidrug transporter by cholesterol and bile acids: effects of mutations in potential substrate and steroid binding sites.
    Telbisz Á; Hegedüs C; Váradi A; Sarkadi B; Özvegy-Laczka C
    Drug Metab Dispos; 2014 Apr; 42(4):575-85. PubMed ID: 24384916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human breast cancer resistance protein (BCRP/ABCG2) shows conformational changes with mitoxantrone.
    Rosenberg MF; Bikadi Z; Chan J; Liu X; Ni Z; Cai X; Ford RC; Mao Q
    Structure; 2010 Mar; 18(4):482-93. PubMed ID: 20399185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization.
    Polgar O; Ozvegy-Laczka C; Robey RW; Morisaki K; Okada M; Tamaki A; Koblos G; Elkind NB; Ward Y; Dean M; Sarkadi B; Bates SE
    Biochemistry; 2006 Apr; 45(16):5251-60. PubMed ID: 16618113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2.
    Litman T; Jensen U; Hansen A; Covitz KM; Zhan Z; Fetsch P; Abati A; Hansen PR; Horn T; Skovsgaard T; Bates SE
    Biochim Biophys Acta; 2002 Sep; 1565(1):6-16. PubMed ID: 12225847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of putative catalytic base mutation E211Q on ABCG2-mediated methotrexate transport.
    Hou YX; Li CZ; Palaniyandi K; Magtibay PM; Homolya L; Sarkadi B; Chang XB
    Biochemistry; 2009 Sep; 48(38):9122-31. PubMed ID: 19691360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.